Hudson Bay Capital Management LP - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 125 filers reported holding RIGEL PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.

Quarter-by-quarter ownership
Hudson Bay Capital Management LP ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$112,500
-97.2%
75,000
-97.8%
0.00%
-97.1%
Q3 2022$3,983,000
-13.5%
3,375,000
-17.2%
0.04%0.0%
Q2 2022$4,605,000
-59.7%
4,075,000
+6.7%
0.04%
-77.4%
Q1 2022$11,421,000
+7.7%
3,819,800
-4.5%
0.16%
+43.5%
Q4 2021$10,600,000
+3.9%
4,000,000
+42.3%
0.11%
-21.7%
Q3 2021$10,200,000
-6.0%
2,810,000
+12.4%
0.14%
+5.3%
Q2 2021$10,850,000
+24.7%
2,500,000
-1.8%
0.13%
+22.4%
Q1 2021$8,704,000
-56.1%
2,544,900
-55.1%
0.11%0.0%
Q4 2020$19,846,000
+159.6%
5,670,000
+78.0%
0.11%
-6.1%
Q3 2020$7,644,000
+25.9%
3,185,000
-4.0%
0.11%
+7.5%
Q2 2020$6,073,000
+11.2%
3,318,849
-5.2%
0.11%
-22.6%
Q1 2020$5,460,000
-15.0%
3,500,000
+16.7%
0.14%
-4.2%
Q4 2019$6,420,000
+24.8%
3,000,000
+9.1%
0.14%
+0.7%
Q3 2019$5,143,000
-11.6%
2,750,000
+23.3%
0.14%
+6.0%
Q2 2019$5,820,000
+6.3%
2,230,000
+4.7%
0.13%
+88.7%
Q1 2019$5,474,000
+13.3%
2,130,000
+1.4%
0.07%
+9.2%
Q4 2018$4,830,000
-23.0%
2,100,000
+7.4%
0.06%
-16.7%
Q3 2018$6,276,000
+10.9%
1,955,000
-2.2%
0.08%
-2.5%
Q2 2018$5,660,000
+27.9%
2,000,000
+60.0%
0.08%
-13.0%
Q1 2018$4,425,000
-8.8%
1,250,0000.0%0.09%
-11.5%
Q4 2017$4,850,000
+52.8%
1,250,0000.0%0.10%
+31.6%
Q3 2017$3,175,000
+16.3%
1,250,000
+25.0%
0.08%
+43.6%
Q2 2017$2,730,000
+449.3%
1,000,000
+566.7%
0.06%
+685.7%
Q1 2017$497,000150,0000.01%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 1,847,087$4,119,0003.26%
Sio Capital Management, LLC 1,333,696$2,974,0001.52%
Boxer Capital, LLC 700,000$1,561,0001.38%
Palo Alto Investors LP 5,386,534$12,012,0000.91%
ACUTA CAPITAL PARTNERS, LLC 747,748$1,667,0000.80%
SENZAR ASSET MANAGEMENT, LLC 1,443,003$3,217,897,0000.70%
Ghost Tree Capital, LLC 800,000$1,784,0000.52%
NEA Management Company, LLC 3,243,150$7,232,0000.38%
Rhenman & Partners Asset Management AB 850,000$1,896,0000.34%
Rock Springs Capital Management LP 1,750,000$3,903,0000.29%
View complete list of RIGEL PHARMACEUTICALS INC shareholders